nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethinyl Estradiol—NR1I2—esophageal cancer	0.371	0.62	CbGaD
Ethinyl Estradiol—ABCC2—esophageal cancer	0.166	0.278	CbGaD
Ethinyl Estradiol—AOX1—Methotrexate—esophageal cancer	0.0892	0.35	CbGbCtD
Ethinyl Estradiol—ABCB1—esophageal cancer	0.0612	0.102	CbGaD
Ethinyl Estradiol—ABCC2—Carboplatin—esophageal cancer	0.0486	0.191	CbGbCtD
Ethinyl Estradiol—ABCC2—Cisplatin—esophageal cancer	0.0415	0.163	CbGbCtD
Ethinyl Estradiol—ABCC2—Methotrexate—esophageal cancer	0.0269	0.106	CbGbCtD
Ethinyl Estradiol—CYP2B6—Cisplatin—esophageal cancer	0.0264	0.104	CbGbCtD
Ethinyl Estradiol—ABCB1—Cisplatin—esophageal cancer	0.0135	0.0531	CbGbCtD
Ethinyl Estradiol—ABCB1—Methotrexate—esophageal cancer	0.00878	0.0345	CbGbCtD
Ethinyl Estradiol—Vaginal pain—Capecitabine—esophageal cancer	0.00271	0.0594	CcSEcCtD
Ethinyl Estradiol—Vulvovaginal pain—Capecitabine—esophageal cancer	0.00271	0.0594	CcSEcCtD
Ethinyl Estradiol—Premenstrual syndrome—Capecitabine—esophageal cancer	0.00223	0.049	CcSEcCtD
Ethinyl Estradiol—NR1I2—digestive system—esophageal cancer	0.00157	0.105	CbGeAlD
Ethinyl Estradiol—Thromboembolic event—Capecitabine—esophageal cancer	0.00136	0.0299	CcSEcCtD
Ethinyl Estradiol—Infarction—Capecitabine—esophageal cancer	0.00132	0.029	CcSEcCtD
Ethinyl Estradiol—Thromboembolic event—Methotrexate—esophageal cancer	0.00101	0.0222	CcSEcCtD
Ethinyl Estradiol—ESR2—neck—esophageal cancer	0.00101	0.0674	CbGeAlD
Ethinyl Estradiol—SHBG—neck—esophageal cancer	0.000981	0.0655	CbGeAlD
Ethinyl Estradiol—Pruritus genital—Capecitabine—esophageal cancer	0.000877	0.0193	CcSEcCtD
Ethinyl Estradiol—Depressed mood—Capecitabine—esophageal cancer	0.000819	0.018	CcSEcCtD
Ethinyl Estradiol—SLC10A1—digestive system—esophageal cancer	0.000782	0.0522	CbGeAlD
Ethinyl Estradiol—ABCB11—digestive system—esophageal cancer	0.000773	0.0516	CbGeAlD
Ethinyl Estradiol—ESR1—neck—esophageal cancer	0.000691	0.0462	CbGeAlD
Ethinyl Estradiol—ESR2—epithelium—esophageal cancer	0.000687	0.0459	CbGeAlD
Ethinyl Estradiol—ESR2—smooth muscle tissue—esophageal cancer	0.000662	0.0442	CbGeAlD
Ethinyl Estradiol—AOX1—bronchus—esophageal cancer	0.000651	0.0435	CbGeAlD
Ethinyl Estradiol—Infection—Carboplatin—esophageal cancer	0.0006	0.0132	CcSEcCtD
Ethinyl Estradiol—Loss of libido—Methotrexate—esophageal cancer	0.00059	0.013	CcSEcCtD
Ethinyl Estradiol—AOX1—trachea—esophageal cancer	0.000585	0.039	CbGeAlD
Ethinyl Estradiol—Embolism—Capecitabine—esophageal cancer	0.00057	0.0125	CcSEcCtD
Ethinyl Estradiol—ESR2—digestive system—esophageal cancer	0.000523	0.0349	CbGeAlD
Ethinyl Estradiol—Thrombosis—Capecitabine—esophageal cancer	0.000517	0.0114	CcSEcCtD
Ethinyl Estradiol—Metrorrhagia—Capecitabine—esophageal cancer	0.000513	0.0113	CcSEcCtD
Ethinyl Estradiol—AOX1—digestive system—esophageal cancer	0.000503	0.0336	CbGeAlD
Ethinyl Estradiol—Body temperature increased—Carboplatin—esophageal cancer	0.000478	0.0105	CcSEcCtD
Ethinyl Estradiol—Fluid retention—Cisplatin—esophageal cancer	0.000472	0.0104	CcSEcCtD
Ethinyl Estradiol—ESR1—epithelium—esophageal cancer	0.00047	0.0314	CbGeAlD
Ethinyl Estradiol—ESR1—smooth muscle tissue—esophageal cancer	0.000453	0.0303	CbGeAlD
Ethinyl Estradiol—Vaginal discharge—Methotrexate—esophageal cancer	0.000448	0.00984	CcSEcCtD
Ethinyl Estradiol—ESR2—lung—esophageal cancer	0.000436	0.0291	CbGeAlD
Ethinyl Estradiol—Embolism—Methotrexate—esophageal cancer	0.000425	0.00933	CcSEcCtD
Ethinyl Estradiol—AOX1—lung—esophageal cancer	0.00042	0.0281	CbGeAlD
Ethinyl Estradiol—Estradiol—NR1I2—esophageal cancer	0.000419	0.15	CrCbGaD
Ethinyl Estradiol—Herpes simplex—Capecitabine—esophageal cancer	0.000397	0.00873	CcSEcCtD
Ethinyl Estradiol—ABCC2—digestive system—esophageal cancer	0.000393	0.0263	CbGeAlD
Ethinyl Estradiol—Cerebrovascular accident—Cisplatin—esophageal cancer	0.000368	0.00808	CcSEcCtD
Ethinyl Estradiol—Blood pressure increased—Capecitabine—esophageal cancer	0.000366	0.00804	CcSEcCtD
Ethinyl Estradiol—ESR1—digestive system—esophageal cancer	0.000358	0.0239	CbGeAlD
Ethinyl Estradiol—Influenza like illness—Capecitabine—esophageal cancer	0.000356	0.00781	CcSEcCtD
Ethinyl Estradiol—Fluid retention—Capecitabine—esophageal cancer	0.000348	0.00764	CcSEcCtD
Ethinyl Estradiol—Irritability—Cisplatin—esophageal cancer	0.000344	0.00756	CcSEcCtD
Ethinyl Estradiol—CYP2B6—bronchus—esophageal cancer	0.000342	0.0229	CbGeAlD
Ethinyl Estradiol—Neoplasm—Capecitabine—esophageal cancer	0.000331	0.00727	CcSEcCtD
Ethinyl Estradiol—Breast disorder—Cisplatin—esophageal cancer	0.000326	0.00716	CcSEcCtD
Ethinyl Estradiol—Estrone—CYP1B1—esophageal cancer	0.000318	0.113	CrCbGaD
Ethinyl Estradiol—Levonorgestrel—CYP19A1—esophageal cancer	0.000318	0.113	CrCbGaD
Ethinyl Estradiol—ESR1—lung—esophageal cancer	0.000299	0.02	CbGeAlD
Ethinyl Estradiol—ESR2—lymph node—esophageal cancer	0.000298	0.0199	CbGeAlD
Ethinyl Estradiol—Herpes simplex—Methotrexate—esophageal cancer	0.000296	0.0065	CcSEcCtD
Ethinyl Estradiol—Danazol—CYP19A1—esophageal cancer	0.000289	0.103	CrCbGaD
Ethinyl Estradiol—AOX1—lymph node—esophageal cancer	0.000287	0.0192	CbGeAlD
Ethinyl Estradiol—Libido decreased—Capecitabine—esophageal cancer	0.000287	0.0063	CcSEcCtD
Ethinyl Estradiol—Hot flush—Capecitabine—esophageal cancer	0.000284	0.00624	CcSEcCtD
Ethinyl Estradiol—Increased appetite—Capecitabine—esophageal cancer	0.000283	0.00621	CcSEcCtD
Ethinyl Estradiol—Menopausal symptoms—Capecitabine—esophageal cancer	0.000282	0.00619	CcSEcCtD
Ethinyl Estradiol—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000274	0.00602	CcSEcCtD
Ethinyl Estradiol—Vaginal inflammation—Methotrexate—esophageal cancer	0.000273	0.00599	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000272	0.00598	CcSEcCtD
Ethinyl Estradiol—Myocardial infarction—Cisplatin—esophageal cancer	0.000272	0.00598	CcSEcCtD
Ethinyl Estradiol—Cerebrovascular accident—Capecitabine—esophageal cancer	0.000271	0.00596	CcSEcCtD
Ethinyl Estradiol—Cystitis noninfective—Methotrexate—esophageal cancer	0.000266	0.00585	CcSEcCtD
Ethinyl Estradiol—Pain in extremity—Capecitabine—esophageal cancer	0.000266	0.00584	CcSEcCtD
Ethinyl Estradiol—CYP2B6—digestive system—esophageal cancer	0.000264	0.0177	CbGeAlD
Ethinyl Estradiol—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.000264	0.00579	CcSEcCtD
Ethinyl Estradiol—Cystitis—Methotrexate—esophageal cancer	0.000263	0.00578	CcSEcCtD
Ethinyl Estradiol—Migraine—Capecitabine—esophageal cancer	0.000262	0.00575	CcSEcCtD
Ethinyl Estradiol—Vaginal infection—Methotrexate—esophageal cancer	0.000257	0.00565	CcSEcCtD
Ethinyl Estradiol—Irritability—Capecitabine—esophageal cancer	0.000254	0.00557	CcSEcCtD
Ethinyl Estradiol—Mood swings—Capecitabine—esophageal cancer	0.000252	0.00553	CcSEcCtD
Ethinyl Estradiol—Conjugated Estrogens—ABCC2—esophageal cancer	0.000249	0.0888	CrCbGaD
Ethinyl Estradiol—Bladder pain—Methotrexate—esophageal cancer	0.000246	0.00541	CcSEcCtD
Ethinyl Estradiol—Neoplasm—Methotrexate—esophageal cancer	0.000246	0.00541	CcSEcCtD
Ethinyl Estradiol—Urinary tract disorder—Cisplatin—esophageal cancer	0.000246	0.00541	CcSEcCtD
Ethinyl Estradiol—Connective tissue disorder—Cisplatin—esophageal cancer	0.000245	0.00538	CcSEcCtD
Ethinyl Estradiol—Methyltestosterone—CYP19A1—esophageal cancer	0.000245	0.0873	CrCbGaD
Ethinyl Estradiol—Urethral disorder—Cisplatin—esophageal cancer	0.000245	0.00537	CcSEcCtD
Ethinyl Estradiol—Estradiol—CYP1B1—esophageal cancer	0.000241	0.086	CrCbGaD
Ethinyl Estradiol—Visual impairment—Cisplatin—esophageal cancer	0.00024	0.00528	CcSEcCtD
Ethinyl Estradiol—Breast disorder—Capecitabine—esophageal cancer	0.00024	0.00528	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Cisplatin—esophageal cancer	0.000233	0.00512	CcSEcCtD
Ethinyl Estradiol—Abdominal distension—Capecitabine—esophageal cancer	0.000231	0.00508	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Cisplatin—esophageal cancer	0.000225	0.00495	CcSEcCtD
Ethinyl Estradiol—ABCC2—lymph node—esophageal cancer	0.000225	0.015	CbGeAlD
Ethinyl Estradiol—Bronchitis—Capecitabine—esophageal cancer	0.000221	0.00485	CcSEcCtD
Ethinyl Estradiol—CYP2B6—lung—esophageal cancer	0.000221	0.0148	CbGeAlD
Ethinyl Estradiol—Alopecia—Cisplatin—esophageal cancer	0.00022	0.00484	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Cisplatin—esophageal cancer	0.000217	0.00477	CcSEcCtD
Ethinyl Estradiol—Dysuria—Capecitabine—esophageal cancer	0.000215	0.00472	CcSEcCtD
Ethinyl Estradiol—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000213	0.00469	CcSEcCtD
Ethinyl Estradiol—Weight increased—Capecitabine—esophageal cancer	0.000209	0.00459	CcSEcCtD
Ethinyl Estradiol—Visual disturbance—Methotrexate—esophageal cancer	0.000209	0.00459	CcSEcCtD
Ethinyl Estradiol—Muscle spasms—Cisplatin—esophageal cancer	0.000209	0.00459	CcSEcCtD
Ethinyl Estradiol—Weight decreased—Capecitabine—esophageal cancer	0.000208	0.00457	CcSEcCtD
Ethinyl Estradiol—Infestation—Capecitabine—esophageal cancer	0.000205	0.0045	CcSEcCtD
Ethinyl Estradiol—Infestation NOS—Capecitabine—esophageal cancer	0.000205	0.0045	CcSEcCtD
Ethinyl Estradiol—ESR1—lymph node—esophageal cancer	0.000204	0.0137	CbGeAlD
Ethinyl Estradiol—Depression—Capecitabine—esophageal cancer	0.000204	0.00449	CcSEcCtD
Ethinyl Estradiol—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000202	0.00444	CcSEcCtD
Ethinyl Estradiol—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000202	0.00444	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Cisplatin—esophageal cancer	0.000201	0.00443	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000201	0.00441	CcSEcCtD
Ethinyl Estradiol—Myocardial infarction—Capecitabine—esophageal cancer	0.000201	0.00441	CcSEcCtD
Ethinyl Estradiol—CYP3A4—digestive system—esophageal cancer	0.0002	0.0133	CbGeAlD
Ethinyl Estradiol—Urinary tract infection—Capecitabine—esophageal cancer	0.000199	0.00437	CcSEcCtD
Ethinyl Estradiol—Malaise—Cisplatin—esophageal cancer	0.000196	0.0043	CcSEcCtD
Ethinyl Estradiol—Estriol—ABCB1—esophageal cancer	0.000192	0.0684	CrCbGaD
Ethinyl Estradiol—Irritability—Methotrexate—esophageal cancer	0.000189	0.00415	CcSEcCtD
Ethinyl Estradiol—Mood swings—Methotrexate—esophageal cancer	0.000187	0.00412	CcSEcCtD
Ethinyl Estradiol—ABCB1—epithelium—esophageal cancer	0.000186	0.0124	CbGeAlD
Ethinyl Estradiol—Haemoglobin—Capecitabine—esophageal cancer	0.000185	0.00406	CcSEcCtD
Ethinyl Estradiol—Rhinitis—Capecitabine—esophageal cancer	0.000184	0.00405	CcSEcCtD
Ethinyl Estradiol—Anxiety—Cisplatin—esophageal cancer	0.000184	0.00405	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Capecitabine—esophageal cancer	0.000184	0.00404	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000184	0.00403	CcSEcCtD
Ethinyl Estradiol—Hypoaesthesia—Capecitabine—esophageal cancer	0.000183	0.00402	CcSEcCtD
Ethinyl Estradiol—Discomfort—Cisplatin—esophageal cancer	0.000183	0.00401	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Capecitabine—esophageal cancer	0.000182	0.00401	CcSEcCtD
Ethinyl Estradiol—Urinary tract disorder—Capecitabine—esophageal cancer	0.000182	0.00399	CcSEcCtD
Ethinyl Estradiol—Connective tissue disorder—Capecitabine—esophageal cancer	0.000181	0.00397	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Capecitabine—esophageal cancer	0.00018	0.00396	CcSEcCtD
Ethinyl Estradiol—Breast disorder—Methotrexate—esophageal cancer	0.000179	0.00393	CcSEcCtD
Ethinyl Estradiol—Estramustine—ABCB1—esophageal cancer	0.000178	0.0636	CrCbGaD
Ethinyl Estradiol—Oedema—Cisplatin—esophageal cancer	0.000177	0.00389	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Capecitabine—esophageal cancer	0.000177	0.00389	CcSEcCtD
Ethinyl Estradiol—Infection—Cisplatin—esophageal cancer	0.000176	0.00387	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Capecitabine—esophageal cancer	0.000174	0.00382	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Cisplatin—esophageal cancer	0.000174	0.00382	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Cisplatin—esophageal cancer	0.000172	0.00378	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Capecitabine—esophageal cancer	0.000172	0.00377	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Capecitabine—esophageal cancer	0.000167	0.00366	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Capecitabine—esophageal cancer	0.000166	0.00365	CcSEcCtD
Ethinyl Estradiol—ABCB1—trachea—esophageal cancer	0.000164	0.011	CbGeAlD
Ethinyl Estradiol—Alopecia—Capecitabine—esophageal cancer	0.000162	0.00357	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Capecitabine—esophageal cancer	0.000161	0.00354	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Capecitabine—esophageal cancer	0.00016	0.00352	CcSEcCtD
Ethinyl Estradiol—Dysuria—Methotrexate—esophageal cancer	0.00016	0.00351	CcSEcCtD
Ethinyl Estradiol—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000159	0.00349	CcSEcCtD
Ethinyl Estradiol—Back pain—Capecitabine—esophageal cancer	0.000155	0.0034	CcSEcCtD
Ethinyl Estradiol—Muscle spasms—Capecitabine—esophageal cancer	0.000154	0.00338	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000153	0.00336	CcSEcCtD
Ethinyl Estradiol—Infestation—Methotrexate—esophageal cancer	0.000152	0.00335	CcSEcCtD
Ethinyl Estradiol—Infestation NOS—Methotrexate—esophageal cancer	0.000152	0.00335	CcSEcCtD
Ethinyl Estradiol—Depression—Methotrexate—esophageal cancer	0.000152	0.00334	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Capecitabine—esophageal cancer	0.000149	0.00326	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Cisplatin—esophageal cancer	0.000146	0.00321	CcSEcCtD
Ethinyl Estradiol—Malaise—Capecitabine—esophageal cancer	0.000144	0.00317	CcSEcCtD
Ethinyl Estradiol—ABCB1—digestive system—esophageal cancer	0.000141	0.00944	CbGeAlD
Ethinyl Estradiol—Body temperature increased—Cisplatin—esophageal cancer	0.00014	0.00308	CcSEcCtD
Ethinyl Estradiol—Cough—Capecitabine—esophageal cancer	0.00014	0.00307	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Methotrexate—esophageal cancer	0.000138	0.00302	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Methotrexate—esophageal cancer	0.000137	0.00301	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Methotrexate—esophageal cancer	0.000136	0.00298	CcSEcCtD
Ethinyl Estradiol—Anxiety—Capecitabine—esophageal cancer	0.000136	0.00298	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000135	0.00297	CcSEcCtD
Ethinyl Estradiol—Urinary tract disorder—Methotrexate—esophageal cancer	0.000135	0.00297	CcSEcCtD
Ethinyl Estradiol—Discomfort—Capecitabine—esophageal cancer	0.000135	0.00296	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Methotrexate—esophageal cancer	0.000134	0.00295	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Methotrexate—esophageal cancer	0.000132	0.0029	CcSEcCtD
Ethinyl Estradiol—Oedema—Capecitabine—esophageal cancer	0.000131	0.00287	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Cisplatin—esophageal cancer	0.000131	0.00287	CcSEcCtD
Ethinyl Estradiol—Infection—Capecitabine—esophageal cancer	0.00013	0.00285	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Methotrexate—esophageal cancer	0.000129	0.00284	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Capecitabine—esophageal cancer	0.000128	0.00281	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Methotrexate—esophageal cancer	0.000128	0.00281	CcSEcCtD
Ethinyl Estradiol—Asthenia—Cisplatin—esophageal cancer	0.000127	0.00279	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Capecitabine—esophageal cancer	0.000127	0.00279	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Methotrexate—esophageal cancer	0.000124	0.00273	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Methotrexate—esophageal cancer	0.000124	0.00272	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Cisplatin—esophageal cancer	0.000121	0.00266	CcSEcCtD
Ethinyl Estradiol—Alopecia—Methotrexate—esophageal cancer	0.000121	0.00266	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Methotrexate—esophageal cancer	0.00012	0.00263	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Methotrexate—esophageal cancer	0.000119	0.00262	CcSEcCtD
Ethinyl Estradiol—ABCB1—lung—esophageal cancer	0.000118	0.00788	CbGeAlD
Ethinyl Estradiol—Back pain—Methotrexate—esophageal cancer	0.000115	0.00253	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000113	0.00248	CcSEcCtD
Ethinyl Estradiol—Vomiting—Cisplatin—esophageal cancer	0.000113	0.00248	CcSEcCtD
Ethinyl Estradiol—Fatigue—Capecitabine—esophageal cancer	0.000113	0.00247	CcSEcCtD
Ethinyl Estradiol—Rash—Cisplatin—esophageal cancer	0.000112	0.00245	CcSEcCtD
Ethinyl Estradiol—Constipation—Capecitabine—esophageal cancer	0.000112	0.00245	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Cisplatin—esophageal cancer	0.000112	0.00245	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Methotrexate—esophageal cancer	0.000111	0.00243	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Capecitabine—esophageal cancer	0.000108	0.00236	CcSEcCtD
Ethinyl Estradiol—Malaise—Methotrexate—esophageal cancer	0.000107	0.00236	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000107	0.00235	CcSEcCtD
Ethinyl Estradiol—Nausea—Cisplatin—esophageal cancer	0.000105	0.00231	CcSEcCtD
Ethinyl Estradiol—Cough—Methotrexate—esophageal cancer	0.000104	0.00228	CcSEcCtD
Ethinyl Estradiol—Urticaria—Capecitabine—esophageal cancer	0.000104	0.00228	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Capecitabine—esophageal cancer	0.000103	0.00227	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Capecitabine—esophageal cancer	0.000103	0.00227	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000101	0.00221	CcSEcCtD
Ethinyl Estradiol—Norethindrone—ABCB1—esophageal cancer	0.000101	0.0359	CrCbGaD
Ethinyl Estradiol—Discomfort—Methotrexate—esophageal cancer	0.0001	0.0022	CcSEcCtD
Ethinyl Estradiol—Infection—Methotrexate—esophageal cancer	9.66e-05	0.00212	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Capecitabine—esophageal cancer	9.62e-05	0.00211	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Methotrexate—esophageal cancer	9.54e-05	0.00209	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Methotrexate—esophageal cancer	9.45e-05	0.00208	CcSEcCtD
Ethinyl Estradiol—Asthenia—Capecitabine—esophageal cancer	9.37e-05	0.00206	CcSEcCtD
Ethinyl Estradiol—Pruritus—Capecitabine—esophageal cancer	9.24e-05	0.00203	CcSEcCtD
Ethinyl Estradiol—Conjugated Estrogens—ABCB1—esophageal cancer	9.15e-05	0.0327	CrCbGaD
Ethinyl Estradiol—Estrone—ABCB1—esophageal cancer	9.12e-05	0.0326	CrCbGaD
Ethinyl Estradiol—Diarrhoea—Capecitabine—esophageal cancer	8.94e-05	0.00196	CcSEcCtD
Ethinyl Estradiol—Dizziness—Capecitabine—esophageal cancer	8.64e-05	0.0019	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Methotrexate—esophageal cancer	8.4e-05	0.00184	CcSEcCtD
Ethinyl Estradiol—Fatigue—Methotrexate—esophageal cancer	8.38e-05	0.00184	CcSEcCtD
Ethinyl Estradiol—Vomiting—Capecitabine—esophageal cancer	8.31e-05	0.00182	CcSEcCtD
Ethinyl Estradiol—Rash—Capecitabine—esophageal cancer	8.24e-05	0.00181	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Capecitabine—esophageal cancer	8.23e-05	0.00181	CcSEcCtD
Ethinyl Estradiol—Headache—Capecitabine—esophageal cancer	8.18e-05	0.0018	CcSEcCtD
Ethinyl Estradiol—ABCB1—lymph node—esophageal cancer	8.07e-05	0.00539	CbGeAlD
Ethinyl Estradiol—Feeling abnormal—Methotrexate—esophageal cancer	8.01e-05	0.00176	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Methotrexate—esophageal cancer	7.95e-05	0.00175	CcSEcCtD
Ethinyl Estradiol—Nausea—Capecitabine—esophageal cancer	7.76e-05	0.0017	CcSEcCtD
Ethinyl Estradiol—Urticaria—Methotrexate—esophageal cancer	7.73e-05	0.0017	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Methotrexate—esophageal cancer	7.69e-05	0.00169	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Methotrexate—esophageal cancer	7.69e-05	0.00169	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Methotrexate—esophageal cancer	7.16e-05	0.00157	CcSEcCtD
Ethinyl Estradiol—Asthenia—Methotrexate—esophageal cancer	6.98e-05	0.00153	CcSEcCtD
Ethinyl Estradiol—Estradiol—ABCB1—esophageal cancer	6.91e-05	0.0247	CrCbGaD
Ethinyl Estradiol—Pruritus—Methotrexate—esophageal cancer	6.88e-05	0.00151	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Methotrexate—esophageal cancer	6.65e-05	0.00146	CcSEcCtD
Ethinyl Estradiol—Dizziness—Methotrexate—esophageal cancer	6.43e-05	0.00141	CcSEcCtD
Ethinyl Estradiol—Vomiting—Methotrexate—esophageal cancer	6.18e-05	0.00136	CcSEcCtD
Ethinyl Estradiol—Rash—Methotrexate—esophageal cancer	6.13e-05	0.00135	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Methotrexate—esophageal cancer	6.13e-05	0.00135	CcSEcCtD
Ethinyl Estradiol—Headache—Methotrexate—esophageal cancer	6.09e-05	0.00134	CcSEcCtD
Ethinyl Estradiol—Nausea—Methotrexate—esophageal cancer	5.78e-05	0.00127	CcSEcCtD
Ethinyl Estradiol—CYP2B6—Metabolism—SLC10A2—esophageal cancer	1.98e-05	0.000239	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—BLVRB—esophageal cancer	1.97e-05	0.000238	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—SLC52A3—esophageal cancer	1.97e-05	0.000238	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	1.97e-05	0.000238	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—PIK3CA—esophageal cancer	1.97e-05	0.000238	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—WIF1—esophageal cancer	1.96e-05	0.000237	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—ABCB1—esophageal cancer	1.96e-05	0.000236	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	1.94e-05	0.000235	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	1.93e-05	0.000233	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	1.93e-05	0.000233	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PTGS1—esophageal cancer	1.92e-05	0.000231	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—ENO1—esophageal cancer	1.92e-05	0.000231	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—TP53—esophageal cancer	1.91e-05	0.000231	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—HIF1A—esophageal cancer	1.91e-05	0.000231	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Generic Transcription Pathway—MYC—esophageal cancer	1.9e-05	0.00023	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	1.89e-05	0.000228	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PSME1—esophageal cancer	1.89e-05	0.000228	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PSME2—esophageal cancer	1.89e-05	0.000228	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CSNK1A1—esophageal cancer	1.81e-05	0.000219	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—CA2—esophageal cancer	1.81e-05	0.000219	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Generic Transcription Pathway—NOTCH1—esophageal cancer	1.78e-05	0.000215	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	1.76e-05	0.000213	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	1.75e-05	0.000211	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—NOS2—esophageal cancer	1.74e-05	0.00021	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	1.73e-05	0.000209	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	1.72e-05	0.000208	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—NOTCH1—esophageal cancer	1.72e-05	0.000208	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.72e-05	0.000208	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—BLVRB—esophageal cancer	1.72e-05	0.000208	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—SLC52A3—esophageal cancer	1.72e-05	0.000208	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—NOTCH1—esophageal cancer	1.7e-05	0.000206	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PFN1—esophageal cancer	1.7e-05	0.000205	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PLCE1—esophageal cancer	1.69e-05	0.000204	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—ADH7—esophageal cancer	1.69e-05	0.000204	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—CA1—esophageal cancer	1.68e-05	0.000203	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—SLC10A2—esophageal cancer	1.68e-05	0.000203	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.65e-05	0.000199	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	1.64e-05	0.000198	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—PSME2—esophageal cancer	1.64e-05	0.000198	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—PSME1—esophageal cancer	1.64e-05	0.000198	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—CYP1B1—esophageal cancer	1.63e-05	0.000197	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Generic Transcription Pathway—CREBBP—esophageal cancer	1.62e-05	0.000195	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	1.59e-05	0.000192	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—CREBBP—esophageal cancer	1.56e-05	0.000189	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—NOTCH3—esophageal cancer	1.55e-05	0.000187	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—CREBBP—esophageal cancer	1.54e-05	0.000186	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—CA2—esophageal cancer	1.53e-05	0.000185	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—CYP19A1—esophageal cancer	1.53e-05	0.000185	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—ELMO1—esophageal cancer	1.52e-05	0.000184	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—CREBBP—esophageal cancer	1.52e-05	0.000184	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.5e-05	0.000181	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—AKAP13—esophageal cancer	1.49e-05	0.00018	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	1.48e-05	0.000179	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—ADH1B—esophageal cancer	1.48e-05	0.000178	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—SLC10A2—esophageal cancer	1.46e-05	0.000177	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CA1—esophageal cancer	1.46e-05	0.000177	CbGpPWpGaD
Ethinyl Estradiol—ABCC2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.45e-05	0.000176	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	1.44e-05	0.000174	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PLCE1—esophageal cancer	1.43e-05	0.000172	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—ADH7—esophageal cancer	1.43e-05	0.000172	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—TYMP—esophageal cancer	1.41e-05	0.000171	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	1.41e-05	0.00017	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.41e-05	0.00017	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—NOS3—esophageal cancer	1.4e-05	0.000169	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—HMOX1—esophageal cancer	1.4e-05	0.000169	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—NOTCH2—esophageal cancer	1.39e-05	0.000168	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—HIST1H2BM—esophageal cancer	1.37e-05	0.000166	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—CYP26A1—esophageal cancer	1.37e-05	0.000166	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.37e-05	0.000166	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PDE4D—esophageal cancer	1.36e-05	0.000164	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—NOS3—esophageal cancer	1.36e-05	0.000164	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—ABCB1—esophageal cancer	1.34e-05	0.000162	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—ALOX15—esophageal cancer	1.34e-05	0.000162	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CA2—esophageal cancer	1.34e-05	0.000161	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—CREBBP—esophageal cancer	1.31e-05	0.000158	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—ERBB2—esophageal cancer	1.31e-05	0.000158	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Gene Expression—MYC—esophageal cancer	1.3e-05	0.000157	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—GNG7—esophageal cancer	1.3e-05	0.000156	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—PTGS2—esophageal cancer	1.28e-05	0.000154	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—GSTO1—esophageal cancer	1.28e-05	0.000154	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—TPI1—esophageal cancer	1.28e-05	0.000154	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	1.27e-05	0.000154	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—ADH1B—esophageal cancer	1.25e-05	0.000151	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—PTGS2—esophageal cancer	1.25e-05	0.00015	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PLCE1—esophageal cancer	1.24e-05	0.00015	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—ADH7—esophageal cancer	1.24e-05	0.00015	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	1.23e-05	0.000149	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—ALDOB—esophageal cancer	1.22e-05	0.000148	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—XIAP—esophageal cancer	1.21e-05	0.000147	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—TYMP—esophageal cancer	1.2e-05	0.000144	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—GAPDH—esophageal cancer	1.18e-05	0.000142	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	1.17e-05	0.000142	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—NOS3—esophageal cancer	1.17e-05	0.000141	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—CRABP1—esophageal cancer	1.17e-05	0.000141	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—SMAD4—esophageal cancer	1.16e-05	0.000141	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—CYP26A1—esophageal cancer	1.16e-05	0.00014	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CTNNA1—esophageal cancer	1.15e-05	0.000139	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CXCL2—esophageal cancer	1.14e-05	0.000138	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—ALOX15—esophageal cancer	1.13e-05	0.000137	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—CDKN1A—esophageal cancer	1.12e-05	0.000135	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—GNG7—esophageal cancer	1.11e-05	0.000134	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—ADH1B—esophageal cancer	1.09e-05	0.000132	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—GSTO1—esophageal cancer	1.08e-05	0.000131	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—TPI1—esophageal cancer	1.08e-05	0.000131	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—PTGS2—esophageal cancer	1.07e-05	0.000129	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.07e-05	0.000129	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PSME2—esophageal cancer	1.07e-05	0.000129	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PSME1—esophageal cancer	1.07e-05	0.000129	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—EP300—esophageal cancer	1.06e-05	0.000128	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—ANXA1—esophageal cancer	1.06e-05	0.000128	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—BLVRB—esophageal cancer	1.06e-05	0.000128	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—SLC52A3—esophageal cancer	1.06e-05	0.000128	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—TYMP—esophageal cancer	1.04e-05	0.000126	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—ALDH2—esophageal cancer	1.04e-05	0.000126	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—ALDOB—esophageal cancer	1.04e-05	0.000125	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—EP300—esophageal cancer	1.04e-05	0.000125	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—SST—esophageal cancer	1.03e-05	0.000125	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	1.02e-05	0.000123	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.01e-05	0.000122	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CYP26A1—esophageal cancer	1.01e-05	0.000122	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—GHRL—esophageal cancer	1.01e-05	0.000121	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—NOTCH3—esophageal cancer	1.01e-05	0.000121	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	1e-05	0.000121	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—GAPDH—esophageal cancer	9.98e-06	0.000121	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—GSTT1—esophageal cancer	9.9e-06	0.00012	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—FBXW7—esophageal cancer	9.89e-06	0.000119	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—CRABP1—esophageal cancer	9.89e-06	0.000119	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—ALOX15—esophageal cancer	9.87e-06	0.000119	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—CYP2A6—esophageal cancer	9.79e-06	0.000118	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Generic Transcription Pathway—MYC—esophageal cancer	9.6e-06	0.000116	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—GSTO1—esophageal cancer	9.42e-06	0.000114	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—TPI1—esophageal cancer	9.42e-06	0.000114	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—GNG7—esophageal cancer	9.41e-06	0.000114	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—ENO1—esophageal cancer	9.28e-06	0.000112	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PTGS1—esophageal cancer	9.28e-06	0.000112	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—MYC—esophageal cancer	9.27e-06	0.000112	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—MYC—esophageal cancer	9.16e-06	0.000111	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PSME2—esophageal cancer	9.14e-06	0.00011	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PSME1—esophageal cancer	9.14e-06	0.00011	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—EGFR—esophageal cancer	9.06e-06	0.000109	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—ALDOB—esophageal cancer	9.03e-06	0.000109	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—NOTCH2—esophageal cancer	9.02e-06	0.000109	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CA1—esophageal cancer	9.01e-06	0.000109	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—SLC10A2—esophageal cancer	9.01e-06	0.000109	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—CREBBP—esophageal cancer	8.96e-06	0.000108	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—EP300—esophageal cancer	8.91e-06	0.000108	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—ALDH2—esophageal cancer	8.81e-06	0.000106	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—GAPDH—esophageal cancer	8.69e-06	0.000105	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	8.68e-06	0.000105	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CRABP1—esophageal cancer	8.62e-06	0.000104	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—NOTCH1—esophageal cancer	8.59e-06	0.000104	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	8.39e-06	0.000101	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—GSTT1—esophageal cancer	8.38e-06	0.000101	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—CYP2A6—esophageal cancer	8.29e-06	0.0001	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	8.26e-06	9.97e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CA2—esophageal cancer	8.24e-06	9.95e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—GNG7—esophageal cancer	8.19e-06	9.9e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—NOS3—esophageal cancer	8.02e-06	9.69e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—TGFBR2—esophageal cancer	8e-06	9.66e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—CYP1B1—esophageal cancer	7.89e-06	9.53e-05	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—PIK3CA—esophageal cancer	7.87e-06	9.5e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PTGS1—esophageal cancer	7.86e-06	9.49e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—ENO1—esophageal cancer	7.86e-06	9.49e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—CREBBP—esophageal cancer	7.79e-06	9.4e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PSME2—esophageal cancer	7.74e-06	9.35e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PSME1—esophageal cancer	7.74e-06	9.35e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—ALDH2—esophageal cancer	7.68e-06	9.27e-05	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—PIK3CA—esophageal cancer	7.66e-06	9.25e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—ADH7—esophageal cancer	7.66e-06	9.25e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PLCE1—esophageal cancer	7.66e-06	9.25e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—SMAD4—esophageal cancer	7.57e-06	9.15e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—CYP19A1—esophageal cancer	7.42e-06	8.96e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PTGS2—esophageal cancer	7.34e-06	8.86e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—GSTT1—esophageal cancer	7.3e-06	8.82e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CYP2A6—esophageal cancer	7.22e-06	8.72e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PTGS1—esophageal cancer	6.84e-06	8.27e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—ENO1—esophageal cancer	6.84e-06	8.27e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	6.84e-06	8.26e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—HMOX1—esophageal cancer	6.77e-06	8.18e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.76e-06	8.16e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PSME2—esophageal cancer	6.74e-06	8.14e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PSME1—esophageal cancer	6.74e-06	8.14e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—ADH1B—esophageal cancer	6.71e-06	8.11e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—CYP1B1—esophageal cancer	6.68e-06	8.07e-05	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—PIK3CA—esophageal cancer	6.59e-06	7.96e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—ABCB1—esophageal cancer	6.5e-06	7.85e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—TYMP—esophageal cancer	6.42e-06	7.75e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—CYP19A1—esophageal cancer	6.28e-06	7.58e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CYP26A1—esophageal cancer	6.24e-06	7.54e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—HIF1A—esophageal cancer	6.2e-06	7.48e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—EP300—esophageal cancer	6.1e-06	7.37e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—ALOX15—esophageal cancer	6.08e-06	7.35e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—KDR—esophageal cancer	5.93e-06	7.16e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CYP1B1—esophageal cancer	5.82e-06	7.03e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—GSTO1—esophageal cancer	5.8e-06	7.01e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—TPI1—esophageal cancer	5.8e-06	7.01e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—HMOX1—esophageal cancer	5.73e-06	6.92e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.62e-06	6.79e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—NOTCH1—esophageal cancer	5.58e-06	6.74e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—ALDOB—esophageal cancer	5.56e-06	6.72e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—ABCB1—esophageal cancer	5.5e-06	6.64e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CYP19A1—esophageal cancer	5.47e-06	6.61e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—GAPDH—esophageal cancer	5.36e-06	6.47e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CRABP1—esophageal cancer	5.31e-06	6.41e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CREBBP—esophageal cancer	5.06e-06	6.11e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—GNG7—esophageal cancer	5.05e-06	6.1e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—HMOX1—esophageal cancer	4.99e-06	6.03e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—ALDH2—esophageal cancer	4.73e-06	5.71e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—MYC—esophageal cancer	4.62e-06	5.58e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—NOS3—esophageal cancer	4.53e-06	5.47e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PIK3CA—esophageal cancer	4.52e-06	5.45e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—GSTT1—esophageal cancer	4.5e-06	5.43e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CYP2A6—esophageal cancer	4.45e-06	5.37e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—CREBBP—esophageal cancer	4.34e-06	5.24e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—ERBB2—esophageal cancer	4.24e-06	5.12e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—ENO1—esophageal cancer	4.22e-06	5.09e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PTGS1—esophageal cancer	4.22e-06	5.09e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.16e-06	5.02e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PSME1—esophageal cancer	4.16e-06	5.02e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PSME2—esophageal cancer	4.16e-06	5.02e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—NOS3—esophageal cancer	3.89e-06	4.7e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CCND1—esophageal cancer	3.75e-06	4.52e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—CREBBP—esophageal cancer	3.68e-06	4.44e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CDKN1A—esophageal cancer	3.62e-06	4.38e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CYP1B1—esophageal cancer	3.59e-06	4.33e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PTGS2—esophageal cancer	3.56e-06	4.29e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—EP300—esophageal cancer	3.45e-06	4.16e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.37e-06	4.07e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—NOS3—esophageal cancer	3.29e-06	3.98e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CREBBP—esophageal cancer	3.2e-06	3.87e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.08e-06	3.72e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PTGS2—esophageal cancer	3.01e-06	3.64e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MYC—esophageal cancer	3e-06	3.63e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—EP300—esophageal cancer	2.96e-06	3.57e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—ABCB1—esophageal cancer	2.95e-06	3.57e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—EGFR—esophageal cancer	2.94e-06	3.55e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—NOS3—esophageal cancer	2.87e-06	3.46e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PTGS2—esophageal cancer	2.62e-06	3.17e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PIK3CA—esophageal cancer	2.55e-06	3.08e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—EP300—esophageal cancer	2.5e-06	3.02e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—TP53—esophageal cancer	2.47e-06	2.98e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PIK3CA—esophageal cancer	2.19e-06	2.64e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—EP300—esophageal cancer	2.18e-06	2.63e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.97e-06	2.38e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PIK3CA—esophageal cancer	1.85e-06	2.24e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—NOS3—esophageal cancer	1.77e-06	2.13e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.62e-06	1.95e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PIK3CA—esophageal cancer	1.61e-06	1.95e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—EP300—esophageal cancer	1.34e-06	1.62e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PIK3CA—esophageal cancer	9.94e-07	1.2e-05	CbGpPWpGaD
